Geneva, July 7 -- International Clinical Trials Registry received information related to the study (ChiCTR2600127262) titled 'Study on the Pathogenesis and Reversal Strategies of Cancer Cachexia Based on Multi-Omics' on June 28.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: The First Affiliated Hospital of China Medical University
Condition:
Gastric cancer
Cancer-related cachexia
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-07-01
Target Sample Size: Observation group:1000;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=327905
Published by HT Digital Content Services with permission from Health Daily Digest....